Early palliative and supportive care for Leukemia

Phase-Based Progress Estimates
Leukemia+4 MoreEarly palliative and supportive care - Other
All Sexes
What conditions do you have?

Study Summary

This trial will compare early palliative care to standard care for patients and their family caregivers undergoing hematopoietic stem cell transplantation for blood cancers.

Eligible Conditions
  • Leukemia
  • Multiple Myeloma
  • Stem Cell Transplant Complications
  • Lymphoma
  • Blood Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 5 years

1 year
1 year overall survival
3 months
Family caregiver quality of life
Patient and family caregiver prognostic understanding
Patient quality of life
Patient symptom burden
5 years
5 year overall survival

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Standard Care
1 of 2
Palliative and Supportive Care Intervention
1 of 2

Active Control

Experimental Treatment

152 Total Participants · 2 Treatment Groups

Primary Treatment: Early palliative and supportive care · No Placebo Group · N/A

Palliative and Supportive Care Intervention
Experimental Group · 1 Intervention: Early palliative and supportive care · Intervention Types: Other
Standard CareNoIntervention Group · 1 Intervention: Standard Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Alberta Health Services, CalgaryLead Sponsor
12 Previous Clinical Trials
2,114 Total Patients Enrolled
Alberta Cancer FoundationOTHER
17 Previous Clinical Trials
5,523 Total Patients Enrolled
1 Trials studying Leukemia
60 Patients Enrolled for Leukemia
University of VictoriaOTHER
48 Previous Clinical Trials
10,130 Total Patients Enrolled
Reanne Booker, PhD(c)Principal InvestigatorAHS Calgary

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to speak, read, and understand English or willing to complete questionnaires with minimal assistance required from an interpreter.
You are a spouse, relative, or friend, identified by the patient, who either lives with the patient or has in-person contact with the patient at least twice per week
You have a diagnosis of hematologic malignancy with scheduled hematopoietic stem cell transplantation.